Dianthus Therapeutics (DNTH) Amortizatization of Intangibles (2022 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Amortizatization of Intangibles of $2.3 million for Q3 2025, down 1.28% year-over-year from $2.3 million in Q3 2024, and up 110.47% quarter-over-quarter from $1.1 million in Q2 2025.
Analysis
Dianthus Therapeutics (DNTH) Amortizatization of Intangibles (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $2.3 million for Q3 2025.
- In Q3 2025, Amortizatization of Intangibles fell 1.28% year-over-year to $2.3 million; the TTM figure through Sep 2025 stood at $8.0 million (up 111.27% YoY), while the FY2024 annual figure was $6.0 million, up 322.91% from the prior year.
- Amortizatization of Intangibles for Q3 2025 stood at $2.3 million, up from $1.1 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $2.7 million in Q4 2024, with the low at $208000.0 in Q2 2023.
- The 4-year median for Amortizatization of Intangibles is $522500.0 (2023), against an average of $1.1 million.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles surged 609.39% in 2024, then dropped 1.28% in 2025.
- Dianthus Therapeutics' Amortizatization of Intangibles stood at $402000.0 in 2022, then soared by 31.09% to $527000.0 in 2023, then soared by 419.35% to $2.7 million in 2024, then declined by 15.56% to $2.3 million in 2025.
- Business Quant data shows DNTH's Amortizatization of Intangibles at $2.3 million in Q3 2025, $1.1 million in Q2 2025, and $1.9 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Dianthus Therapeutics | 4.09 Bn | 3.69 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2.31 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Sep 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 422,000.00 |
| Mar 31, 2024 | 518,000.00 |
| Dec 31, 2023 | 527,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Jun 30, 2023 | 208,000.00 |
| Mar 31, 2023 | 358,000.00 |
| Dec 31, 2022 | 402,000.00 |
| Mar 31, 2022 | 699,000.00 |